Animal Drugs Market Size By Product (Drugs {Antiparasitic, Anti-inflammatory, Anti-infectives}, Vaccines {Modified Live Vaccines [MLV], Killed Inactivated Vaccines}, Medicated Feed Additives {Antibiotics, Vitamins, Amino Acids, Enzymes, Antioxidants, Prebiotics and Probiotics, Minerals}, By Animal Type (Livestock Animals {Poultry, Swine, Cattle, Fish}, Companion Animals {Dogs, Cats, Horses}), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacy and Drug Stores, E-commerce), Industry Analysis Report, Regional, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Nov 2019  |  Report ID: GMI4445  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 200   |   Base Year: 2018

Summary Table of Contents Industry Coverage Methodology

Industry trends

Animal Drugs Market size surpassed USD 29 billion in 2018 and is expected to achieve over 4.9% CAGR up to 2025.

Animal Drugs Market

Get more details on this report - Request Free Sample PDF

Animal health industry includes veterinary services, vaccines, medical devices, animal drugs and supplies for both companion and production animals. An animal drug (veterinary drug) refers to a drug intended for the use in treatment, prevention, diagnosis, cure and mitigation of diseases in animals. Many antibiotics are approved for use in animals. From past few years, prominent pharma players are emphasizing on developing healthcare products for companion animals. Moreover, the animal sector has witnessed technological advances and scientific innovations such as anti-neoplastic animal drugs and genomic tests among others.

The animal health market value is booming at a significant rate across the globe. Different factors such as increasing demand for animal drugs with government support for pet care fosters business growth. In 2000s, Centre for Veterinary Medicine (CVM) a division of FDA started taking responsibility to assure the effectiveness and safety of animal drugs. Furthermore, availability of different animal drugs such as antiparasitic, anti-inflammatory and anti-infectives used to manage animal health effectively should propel the industry growth.

Animal Drugs Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: USD 29.6 Billion
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 4.9% 2025 Value Projection: USD 41.2 Billion
Pages: 200 Tables, Charts & Figures: 303
Geographies covered (21): U.S., Canada, Germany, UK, France, Italy, Spain, Poland, The Netherlands, China, India, Japan, Australia, South Korea, Taiwan, Brazil, Mexico, Argentina, South Africa, GCC Countries, Israel
Segments covered: Product, Animal Type, Route of Administration, Distribution Channel and Region
Companies covered (8): Bayer, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals, Elanco, Merck, Virbac and Zoetis
Growth Drivers:
  • Surging demand for pet insurance policies worldwide
  • Rising rate of obesity in companion animals
  • Increasing government support for pet care across the globe
  • Growing demand for online veterinary pharmacies
Pitfalls & Challenges:
  • High cost associated with animal drugs

Request 15% Free Customization on this Report

Increasing demand for pet insurance schemes across the globe will surge the market demand for animal drugs 

Surging market demand for pet insurance and growing pet adoption across the globe drives animal drugs market share. Several pet insurance policies cover a certain part of the body damage or entire body damage for expensive animal drugs and procedures. Different organizations and insurance companies invest in introducing secured animal insurance plans, thereby, augment animal drugs industry progress. However, high cost associated with animal drugs coupled with increasing zoonotic diseases might restrict the market expansion during the analysis period.

Vaccines efficiently treat animal diseases that proves beneficial for the segmental progress

Based on product, the market is segmented into animal drugs, vaccines and medicated feed additives. Vaccines segment accounted for around USD 7 billion in 2018. The segment includes modified live vaccines and killed inactivated vaccines among others. Animal vaccines are stored at an appropriate temperature, if not it can lose the effectiveness or potency. These vaccines are regulated by the U.S. Department of Agriculture and Centre for Veterinary Biologics. Growing availability of live and killed inactivated vaccines will favour the segmental growth.

Increasing demand for animal protein will provide lucrative market growth opportunities

Based on animal type, the market is fragmented into livestock animals and companion animals. Livestock animals covers poultry, swine, cattle, fish among others, and is accounted for more than 60% animal drugs market share in 2018. The segmental progress is attributed to surged adoption of animal protein-based diets and need to maximize the production from livestock animals. Moreover, livestock farming practices have shifted towards intensive animal farming known as factory farming that increases the yield of several commercial outputs. Thus, aforementioned factors prove beneficial for the animal drugs industry demand.

Oral dosage is least painful as compared to injectables that should propel the segmental growth

Based on route of administration, the market is fragmented into oral, injectable, topical and others. The oral segment accounted for more than USD 7 billion in 2018. The oral route of administration is commonly used in both livestock and companion animals. Suspensions, solutions, capsules, as well as tablets forms of animal drugs are administrated orally in cattle, pigs, and poultry to improve their health conditions and production. Various benefits associated with oral animal drugs such as least pain, requires no skin penetration and reduced risk for acquiring infections surges demand for oral dosage. Hence, the above-mentioned factors will eventually propel the segment expansion.

Affordable health treatments at veterinary hospitals will contribute to the business growth

Animal Drugs Market Statistics By Distribution Channel

Get more details on this report - Request Free Sample PDF

Based on distribution channel, the market is segmented into veterinary hospitals, veterinary clinics, pharmacy and drug stores and e-commerce. Veterinary hospitals segment is projected to witness around 4% CAGR. Veterinary hospitals provide several insurance plans with maximum coverage schemes for better diagnosis of animals. Additionally, benefits offered such as corrective health treatments, quality treatment, early detection of disease, affordable and preventive healthcare, favours the segmental growth. 

Favorable reimbursement policies for animal health should foster the market progress

North America Animal Drugs Market By Country

Get more details on this report - Request Free Sample PDF

North American market will witness around 4% CAGR owing to a surging incidences of animal diseases in the region. Further, Regional growth can be attributed to strong foothold of industry players as well as veterinary hospitals, clinics and drug stores. North America Pet Health Insurance Association is one of the major government organization that collectively works with insurance providers and professionals that will drive the market trends.


U.S. animal drugs market share accounted for over USD 10 billion in 2018, owing to favourable reimbursement policies for animal drugs. Presence of various organizations and associations working towards securing animal health should foster the country growth. Additionally, surging demand for insurance of exotic breeds of dogs and cats should propel the market demand.

The animal drugs industry players implement several organic and in-organic strategies to capitalize on market growth opportunities 

Some of the prominent market players operating in animal drugs industry are Bayer, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals, Elanco, Merck, Virbac and Zoetis. These eminent market players strategically execute various in-organic growth strategies to sustain market competition.

Some of the recent industry developments:

  • In December 2018, Bayer Animal Health partnered with ParaTheraTech, Inc. for advancement of cryptosporidiosis treatment for farm animals. This partnership enabled Bayer to cater to the growing needs of its customers and strengthened its market presence.
  • In November 2016, Bimeda, Inc. acquired Ceva Animal Health. This acquisition was a major milestone in Bimeda’s expansion in the equine market.

The animal drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:

Market Analysis By Product

  • Drugs
    • Antiparasitic
    • Anti-inflammatory
    • Anti-infectives
    • Others
  • Vaccines
    • Modified live vaccines (MLV)
    • Killed inactivated vaccines
    • Others
  • Medicated feed additives
    • Antibiotics
    • Vitamins
    • Amino acids
    • Enzymes
    • Antioxidants
    • Prebiotics and probiotics
    • Minerals
    • Others

By Animal Type

  • Livestock animals
    • Poultry
    • Swine
    • Cattle
    • Fish
    • Others
  • Companion animals
    • Dogs
    • Cats
    • Horses
    • Others

By Route of Administration

  • Oral
  • Injectable
  • Topical
  • Others

By Distribution Channel

  • Veterinary hospitals
  • Veterinary clinics
  • Pharmacy and drug stores
  • E-commerce

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Poland
    • The Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Taiwan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Israel

Frequently Asked Questions (FAQ) :

An animal drug refers to a drug intended for the use in treatment, prevention, diagnosis, cure and mitigation of diseases in animals.
The U.S. animal drugs market led the global industry with $10 billion revenue share in 2018.
Zoetis, Merck, Ulticare, TaiDoc, Bayer, Boehringer Ingelheim Vetmedica Inc. and Allison Medical are the prominent companies operating in the global industry.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust

  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

GMIPulse Subscription

An interactive business analytics platform; designed to assist clients in accessing and analyzing market data on real-time basis.

Start Your Free Trial
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X